Is the primary active ingredient.
Cognitive impairment associated with age-related decline or neurodegenerative diseases (e.g., Alzheimer's disease, vascular dementia). Note: Efficacy varies and may be used as adjunctive therapy.
Traumatic brain injury (TBI), to potentially improve neurological outcomes. Note: Used as supportive therapy and efficacy varies.
Treatment of acute ischemic stroke (AIS), aiding in neurological recovery.
Other neurological conditions, such as glaucoma, where neuroprotection is beneficial (offlabel use).
Neurospark 500mg Tab (Citicoline) is a precursor to phosphatidylcholine, a vital component of cell membranes, particularly in brain tissue. It enhances the synthesis of phosphatidylcholine, leading to improved neuronal membrane integrity and function. This supports neurotransmission, improves cerebral blood flow, and potentially reduces neuronal damage from ischemic events. Further research is ongoing to fully elucidate its mechanisms.
Store in a cool, dry place away from direct sunlight and moisture. Protect from freezing. Follow specific storage instructions on the product label.
Dosage varies depending on the indication, patient's condition, and physician's recommendation. It is crucial to adhere to the prescribed dosage.
Citicoline is available in various forms (oral capsules, intravenous injections). Route and frequency of administration will be determined by the prescribing physician.
Always follow the instructions provided by your doctor or pharmacist.
Gastrointestinal disturbances (e.g., nausea, diarrhea, abdominal pain)
Headache
Dizziness
Insomnia
Allergic reactions (rare)
The interaction between citicoline and alcohol is not extensively studied; however, it is advisable to limit alcohol intake while using citicoline.
Citicoline may cause dizziness or drowsiness in some individuals. Avoid driving or operating heavy machinery until you know how citicoline affects you.
The safety of citicoline during pregnancy and breastfeeding is not fully established. Consult your doctor before using citicoline if you are pregnant, breastfeeding, or planning to become pregnant.
Use in children is generally not well-studied. Dosage and safety should be determined by a pediatrician.
Renal impairment may affect the elimination of citicoline. Dosage adjustments might be necessary in individuals with kidney disease.
Hepatic impairment may affect the metabolism of citicoline. Dosage adjustments might be necessary in individuals with liver disease.
List credible medical journals and databases here (e.g., PubMed, specific clinical trials). This section should be populated with actual references.
